In PD, the frequency of ABCB1 phenotypes is 24.76% for low responders (LR), 32.67% for intermediate responders (IR), and 42.57% for high responders (HR), with no significant differences in response to AtreMorine among the phenotypes [75]. This evidence concerns the gene ABCB1 and Parkinson disease.